Mutations at BRCA1: The medullary breast carcinoma revisited

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1588-1592

  Eisinger, François ^a   Jacquemier, Jocelyne ^a   Charpin, Colette ^b   Stoppa Lyonnet, Dominique ^c   Bressac De Paillerets, Brigitte ^d   Peyrat, Jean Philippe ^e   Longy, Michel ^f   Guinebretière, Jean Marc ^d   Sauvan, Richard ^a   Noguchi, Tetsuro ^a   Birnbaum, Daniel ^a,g   Sobol, Hagay ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b TIMONE HOSPITAL   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Oscar Lambret Centre   (France)

^f INSTITUT BERGONIÉ   (France)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA, MEDULLARY; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; HUMANS; MUTATION;

EID: 0032522462     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Easton, D. F., Bishop, D. T., Ford, D., Crockford, G. P., and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet., 52: 678-701, 1993.
2. Eisinger, F., Stoppa-Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C. Vincent-Salomon, A., Jacquemier, J., Birnbaum, D., and Sobol, H. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res., 56: 471-474, 1996.
3. Marcus, J., Watson, P., Page, D., Narod, S., Lenoir, S., Tonin, P., Linder-Stephenson, L., Conway, T., and Lynch, H. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.
4. The Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349: 1505-1510, 1997.
5. Eisinger, F., Jacquemier, J., Guinebretière, J-M., Birnbaum, D., and Sobol, H. p53 involvement in BRCA1-associated breast cancer. Lancet, 350: 1101, 1997.
6. Johannsson, O., Idvall, I., Anderson, C., Borg, A., Barkardottir, R., Egilson, V., and Olsson, H. Tumor biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer, 33: 362-371, 1997.
7. Porter, D., Cohen, B., Wallace, M., Smyth, E., Chetty, U., Dixon, J., Steel, M., and Carter, D. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br. J. Surg., 81: 1512-1515, 1994.
8. Ridolfi, R., Osen, P., Port, A., Kinne, D., and Mike, V. Medullary carcinoma of the breast: a clinicopathologic study with 10 years follow-up. Cancer (Phila.), 40: 1365-1385, 1977.
9. Rapin, V., Contesso, G., Mouriesse, H., Bertin, F., Lacombe, M., Piekarski, J., Travagli, J., Gadenne, C., and Friedman, S. Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer (Phila.), 61: 2503-2510, 1988.
10. Lidang Jensen, M., Kiaer, H., Andersen, J., Jensen, V., and Melsen, F. Prognosis comparison of three classifications for medullary carcinomas of the breast. Histopathology (Oxford), 30: 523-532, 1997.
11. Sobol, H., Stoppa-Lyonnet, D., Bressac-de-Paillerets, B., Peyrat, J. P., Kerangueven, F., Janin, N., Noguchi, T., Eisinger, F., Guinebretière, J. M., Jacquemier, J., and Birnbaum, D. Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res., 56: 3216-3219, 1996.
12. Stoppa-Lyonnet, D., Laurent-Puig, P., Essioux, L., Pages, S., Ithier, G., Ligot, L., Fourquet, A., Salmon, R., Clough, K., Pouillart, P., The ICBCG, Bonaiti-Pellié, C., and Thomas, G. BRCA1 sequence variations in 160 individuals referred to a breast/ ovarian family cancer clinic. Am. J. Hum. Genet., 60: 1021-1030, 1997.
13. Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E., and King, M-C. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat. Genet., 8: 399-404, 1994.
14. Brow, M. A. D., Oldenburg, M. C., Lyamichev, V., Heisler, L. M., Lymicheva, N., Hall, J. G., Eagan, N. J., Olive, D. M., Smith, L. M., Fors, L., and Dahlberg, J. E. Differentiation of bacterial 16S rRNA genes and intergenic regions and mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage. J. Clin. Microbiol., 34: 3129-3137, 1996.
15. Mallory, F. B. Tumors: Principles of Pathologic Histology, pp. 379-384. Philadelphia: W. B. Saunders, 1914.
16. Reinfuss, M., Stelmach, A., Mitus, J., and Duda, C. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J. Surg. Oncol., 60: 89-94, 1995.
17. Natarajan, N., Nemoto, T., Mettlin, C., and Marphy, G. Race related difference in breast cancer patients: results of the 1982 national survey of breast cancer by American college of surgeons. Cancer (Phila.), 56: 1704-1709, 1985.
18. Rosen, P., Ashikari, R., and Thaler, H. A comparative study of some pathologic features of mammary carcinoma in Tokyo, Japan, and New York, USA. Cancer (Phila.), 39: 429-434, 1977.
19. Pedersen, L., Hoick, S., Schiodt, T., Zeleder, K., and Mouridsen, H. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognosis implication. Breast Cancer Res. Treat., 14: 91-99, 1989.
20. Marcus, J., Page, D., Watson, P., Narod, S., Lenoir, G., and Lynch, H. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer (Phila.), 80: 543-556, 1997.
21. Friend, S., Borresen, A., Brody, L., Casey, G., Devilee, P., Gayther, S., Goldgar, D., Murphy, P., Weber, B., and Wiseman, R. Breast cancer information on the web. Nat. Genet., 11: 238-239, 1995.
22. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Söderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J. D., Marks, J., Ballinger, D. G., Barrett, J. C., Skolnick, M. H., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
23. Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C., and Frank, T. S. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet., 9: 439-443, 1995.
24. Rebbeck, T., Couch, F., Kant, J., Calzone, K., DeShano, M., Peng, Y., Chen, K., Garber, J., and Weber, B. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am. J. Hum. Genet., 59: 547-553, 1996.
25. Stratton, J., Gayther, S., Russel, P., Dearden, J., Gore, M., Blake, P., Easton, D., and Ponder, B. Contribution of BRCA1 mutations to ovarian cancer. N. Engl. J. Med., 336: 1125-1130, 1997.
26. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hyssey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrisson, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Albright, L. C., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene RRCA1. Science (Washington DC), 266: 66-71, 1994.
27. Ford, D., Easton, F., and Peto, J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet., 57: 1457-1462, 1995.
28. Tirkkonen, M., Johannsson, O., Agnarsson, B., Olsson, H., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J., Barkardottir, R., Borg, A., and Kallioniemi, O. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57: 1222-1227, 1997.
29. Kerangueven, F., Noguchi, T., Coulier, F., Aliione, F., Wargniez, V., Simony-Lafontaine, J., Longy, M., Jacquemier, J., Sobol, H., Eisinger, F., and Birnbaum, D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57: 5469-5474, 1997.
30. Langston, A., Malone, K., Thompson, J., Daling, J., and Ostrander, E. BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med., 334: 137-142, 1996.